Top doctors raised concerns about domestically made drugs, saying Beijing’s effort to lower costs is sacrificing quality.

These are some of the problems that doctors have encountered in China’s public hospitals. They have been speaking out in recent weeks, questioning the quality of the country’s drugs and urging reform ...

Criticism over how the Chinese government buys drugs for its public health care system has ignited frustration over the ...

Like many industries preparing for Donald Trump's second term as president, the prospects for the healthcare industry are a ...

The supply chain for drugs poisoning America has become highly concentrated and vulnerable, depending on illegal activities in Communist China and Mexico.

Panama President José Raúl Mulino says there will be no negotiation with the United States over ownership of the Panama Canal ...

President Donald Trump on Tuesday warned that even more tariffs could be coming as soon as next week: This time China was his ...

The Food and Drug Administration uses import alerts to enforce U.S. food safety regulations for food from foreign countries. The agency updates and ...

XtalPi Holdings, an artificial intelligence (AI) drug discovery firm based in the Greater Bay Area, is changing the ...

A combination of an SGLT-2 inhibitor drug and a moderately calorie-restrictive diet leads to higher rates of type 2 diabetes ...

The biotech said it has dosed the first participant in a Phase 3 study of its in vivo gene editing treatment. Elsewhere, the FDA imposed a hold on Atara and lifted another on Amylyx.

Authorities in China are investigating reports of quality problems with some drugs eligible for distribution through the ...